Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015
(Thomson Reuters ONE) -
GAITHERSBURG, Md., Feb. 19, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc.
(Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery,
development and commercialization of recombinant nanoparticle vaccines and
adjuvants, today announced it will report its fourth quarter and full year 2014
financial and operating results after the close of U.S. financial markets on
Thursday, February 26, 2015.
In addition, management will host a conference call to discuss the quarterly and
year-end financial results and provide an update on corporate activities.
Conference call details are as follows:
Date: February 26, 2015
Time: 4:30 pm US Eastern Time
Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International)
Via web: www.novavax.com
Conference call replay:
Dates: Starting at 6:31 pm ET on February 26, 2015 until midnight
March 5, 2015
Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International)
Passcode: 89629680
Via web: www.novavax.com, "Investor Info"/"Events"
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to
delivering novel products to prevent a broad range of infectious diseases. Our
recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the
foundation for groundbreaking innovation that improves global health through
safe and effective vaccines. Additional information about Novavax is available
on the company's website, novavax.com.
CONTACT: Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
240-268-2000
ir(at)novavax.com
Novavax, Inc.
David Schull or Todd Davenport, Ph.D.
Russo Partners, LLC
212-845-4271
david.schull(at)russopartnersllc.com
todd.davenport(at)russopartnersllc.com
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Novavax, Inc. via GlobeNewswire
[HUG#1896020]
Unternehmensinformation / Kurzprofil:
Datum: 19.02.2015 - 22:06 Uhr
Sprache: Deutsch
News-ID 373025
Anzahl Zeichen: 2806
contact information:
Town:
Maryland
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 197 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015"
steht unter der journalistisch-redaktionellen Verantwortung von
Novavax, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
